Purchases and Sales Made in Q2 2024 in Trevi Therapeutics, Inc. (TRVI)
This table provides information about the institutional ownership of Trevi Therapeutics, Inc. (TRVI) during Q2 2024. The information is specifically focused on institutions that hold shares of Trevi Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 14, 2024
Q2 2024
|
Ameriprise Financial Inc
Minneapolis, MN |
SELL
|
- |
-6.66K- 30.82% |
$16.3K - $22.4K
|
14.9K
$97.2K
|
|
|
Jul 25, 2024
Q2 2024
|
Pfs Partners, LLC
Mine Hill, NJ |
SELL
|
- |
-20K- 20.2% |
$48.8K - $67.2K
|
79K
$514K
|
|
|
Aug 13, 2024
Q2 2024
|
Ubs Group Ag
|
SELL
|
- |
-24.1K- 57.24% |
$58.8K - $81K
|
18K
$117K
|
|
|
Aug 14, 2024
Q2 2024
|
Shay Capital LLC
New York, NY |
SELL
|
- |
-25.2K- 22.17% |
$61.5K - $84.7K
|
88.5K
$575K
|
|
|
Aug 09, 2024
Q2 2024
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-64.9K- 55.58% |
$158K - $218K
|
51.9K
$337K
|
|
|
Dec 26, 2024
Q2 2024
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-69.2K- 68.81% |
$169K - $232K
|
31.4K
$204K
|
|
|
Aug 12, 2024
Q2 2024
|
Landscape Capital Management, L.L.C.
|
SELL
|
- |
-135K- 18.2% |
$329K - $453K
|
605K
$3.94M
|
|
|
Aug 13, 2024
Q2 2024
|
Rubric Capital Management LP
New York, NY |
SELL
|
- |
-537K- 9.65% |
$1.31M - $1.8M
|
5.03M
$32.7M
|